Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
New Oncolines publication in Cancers
IL4I1 in ascites as a marker in high-grade serous ovarian cancer [...]
Oncolines Team Joins Symeres
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities [...]
New in Frontiers in Oncology: comparative profiling study of newly approved kinase inhibitors
In the last two decades, nearly 60 small molecule kinase [...]
Case study – Gene expression profiling to understand and combat drug resistancejanneke2022-04-14T11:52:58+02:00
Combination matrix to determine Bliss independence synergy scoresNTRC Oncolines2021-11-17T16:21:49+01:00
Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancerNTRC Oncolines2023-01-07T17:10:15+01:00
Case study – Synergistic interaction of olaparib and cisplatinNTRC Oncolines2021-10-21T11:38:40+02:00
